Loading clinical trials...

Melody® Transcatheter Pulmonary Valve Post-Approval Study | Clinical Trials | Clareo Health

COMPLETEDNANCT01186692

Melody® Transcatheter Pulmonary Valve Post-Approval Study

The purpose of this study is to confirm the short-term hemodynamic effectiveness results achieved by real-world providers are equivalent to the historical control established in the IDE study.

Lead sponsor: Medtronic Cardiovascular•10 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment131

Start dateJul 2010

Last updatedMay 1, 2019

Condition

Dysfunctional Right Ventricular Outflow Tract (RVOT) Conduit

Locations shown

Rady Children's Hospital

San Diego, California

Advocate Hope Children's Hospital

Oak Lawn, Illinois

CS Mott Children's Hospital, University of Michigan

Ann Arbor, Michigan

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 1, 2019Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions